Literature DB >> 6476915

Hypogammaglobulinaemia associated with gold therapy.

A K So, S A Peskett, A D Webster.   

Abstract

Two patients with seronegative arthropathy were noted to be hypogammaglobulinaemic after receiving gold. The clinical course and features suggest that gold is a cause of immunodeficiency.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6476915      PMCID： PMC1001411          DOI： 10.1136/ard.43.4.581

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  7 in total

1.  The simultaneous occurrence of rheumatoid arthritis and agammaglobulinemia.

Authors:  R A GOOD; J ROTSTEIN; W F MAZZITELLO
Journal:  J Lab Clin Med       Date:  1957-03

2.  Drug-induced IgA deficiency in rheumatoid arthritis.

Authors:  D R Stanworth; J P Williamson; M Shadforth; D Felix-Davies; R Thompson
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

3.  Chrysotherapy. Suppression of immunoglobulin synthesis.

Authors:  A Lorber; T Simon; J Leeb; A Peter; S Wilcox
Journal:  Arthritis Rheum       Date:  1978 Sep-Oct

4.  IgA deficiency in juvenile chronic polyarthritis.

Authors:  D O Barkley; H J Hohermuth; A Howard; D B Webster; B M Ansell
Journal:  J Rheumatol       Date:  1979 Mar-Apr       Impact factor: 4.666

5.  Polyarthritis in adults with hypogammaglobulinaemia and its rapid response to immunoglobulin treatment.

Authors:  A D Webster; G Loewi; R D Dourmashkin; D N Golding; D J Ward; G L Asherson
Journal:  Br Med J       Date:  1976-05-29

6.  Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

7.  The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes.

Authors:  M A Scheinberg; L M Santos; A E Finkelstein
Journal:  J Rheumatol       Date:  1982 May-Jun       Impact factor: 4.666
  7 in total
  7 in total

Review 1.  Genetics of IgA deficiency and common variable immunodeficiency.

Authors:  H W Schroeder
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.

Authors:  M Farr; E Tunn; P A Bacon; D H Smith
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

3.  Antibody deficiency associated with gold treatment: natural history and management in 22 patients.

Authors:  N Snowden; D M Dietch; L S Teh; R C Hilton; M R Haeney
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

4.  Association between rheumatoid arthritis and chronic bronchial suppuration.

Authors:  A Bamji; N T Cooke
Journal:  Ann Rheum Dis       Date:  1984-12       Impact factor: 19.103

5.  Hypogammaglobulinaemia associated with gold therapy.

Authors:  T Hunter
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

6.  The clinical value of measuring immunoglobulins when assessing penicillamine therapy in rheumatoid arthritis.

Authors:  A Williams; D L Scott; A Greenwood; E C Huskisson
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

7.  Adult acquired combined immune deficiency in a patient with rheumatoid arthritis on gold.

Authors:  D O Haskard; D Macfarlane
Journal:  J R Soc Med       Date:  1988-09       Impact factor: 18.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.